These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7582819)

  • 1. The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice.
    de Angelis L; Furlan C
    Neurobiol Learn Mem; 1995 Sep; 64(2):119-24. PubMed ID: 7582819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptic muscarinic antagonist secoverine in mice.
    Ammassari-Teule M; Castellano C; Sansone M
    Behav Brain Res; 1992 Mar; 47(1):93-5. PubMed ID: 1571105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injections of tacrine and scopolamine into the nucleus accumbens: opposing effects of immediate vs delayed posttrial treatment on memory of an open field.
    Schildein S; Huston JP; Schwarting RK
    Neurobiol Learn Mem; 2000 Jan; 73(1):21-30. PubMed ID: 10686121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice.
    Hlinák Z; Krejcí I
    Behav Brain Res; 2002 Jul; 133(2):395-9. PubMed ID: 12110475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.
    Preda L; Alberoni M; Bressi S; Cattaneo C; Parini J; Canal N; Franceschi M
    Psychopharmacology (Berl); 1993; 110(4):421-6. PubMed ID: 7870912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine amnesia of passive avoidance: a deficit of information acquisition.
    Rush DK
    Behav Neural Biol; 1988 Nov; 50(3):255-74. PubMed ID: 3202811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task.
    Pitsikas N; Algeri S
    Pharmacol Biochem Behav; 1992 Nov; 43(3):949-51. PubMed ID: 1448491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine.
    Ukai M; Kobayashi T; Kameyama T
    Gen Pharmacol; 1994 May; 25(3):433-8. PubMed ID: 7926587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic Acid: a promising memory-enhancer in mice.
    Parle M; Dhingra D
    J Pharmacol Sci; 2003 Oct; 93(2):129-35. PubMed ID: 14578579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strength of scopolamine-induced amnesia as a function of time between training and testing.
    Quartermain D; Leo P
    Behav Neural Biol; 1988 Nov; 50(3):300-10. PubMed ID: 3202813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nootropic drugs in a scopolamine-induced amnesia model in mice.
    Verloes R; Scotto AM; Gobert J; Wülfert E
    Psychopharmacology (Berl); 1988; 95(2):226-30. PubMed ID: 3137602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice.
    Sansone M; Libri V; Pavone F; Ammassari-Teule M
    Arch Int Pharmacodyn Ther; 1988; 291():208-16. PubMed ID: 3365063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GABAB receptor antagonist CGP 36,742 and the nootropic oxiracetam facilitate the formation of long-term memory.
    Mondadori C; Möbius HJ; Borkowski J
    Behav Brain Res; 1996 May; 77(1-2):223-5. PubMed ID: 8762175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain entry and direct central pharmacological effects of the nootropic drug oxiracetam. Oxiracetam: brain entry and pharmacological effects.
    Ponzio F; Pozzi O; Banfi S; Dorigotti L
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():111-5. PubMed ID: 2602442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task.
    Azami NS; Piri M; Oryan S; Jahanshahi M; Babapour V; Zarrindast MR
    Neurobiol Learn Mem; 2010 May; 93(4):455-62. PubMed ID: 20064624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time gradient for post-test vulnerability to scopolamine-induced amnesia following the initial acquisition session of a spatial reference memory task in mice.
    Toumane A; Durkin TP
    Behav Neural Biol; 1993 Sep; 60(2):139-51. PubMed ID: 8117239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine receptor ligand influences on acquisition: suggestion of an endogenous modulatory mechanism mediated by benzodiazepine receptors.
    Izquierdo I; Pereira ME; Medina JH
    Behav Neural Biol; 1990 Jul; 54(1):27-41. PubMed ID: 1974134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention enhancement by pre-test beta-endorphin and oxotremorine and its reversal by scopolamine.
    Brioni JD; Izquierdo I
    Behav Neural Biol; 1988 Nov; 50(3):251-4. PubMed ID: 2849408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.